The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Exercise of Options and Total Voting Rights

1 Aug 2019 07:00

RNS Number : 4667H
CVS Group plc
01 August 2019
 

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

 

CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, confirms that it has issued a total of 15,252 new ordinary shares of 0.2 pence each ("Ordinary Shares") during July, as a result of the exercise of options by certain employees under the Company's Save As You Earn (SAYE) 2015/2018 scheme (the "SAYE Shares").

The SAYE Shares rank pari passu with all existing Ordinary Shares and admission has been satisfied via the Company's block listing, application for which was announced on 19 December 2018.

Following the above new issuance, the Company has a total issued share capital at the date of this announcement of 70,651,192 Ordinary Shares each carrying one voting right.

The Company does not hold any Ordinary Shares in treasury. The total number of voting rights is therefore 70,651,192. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Contacts:

CVS Group Plc Tel: 01379 644288

Simon Innes, Chief Executive

Richard Fairman, Finance Director

 

N+1 Singer (Nominated Adviser & Broker) Tel: 0207 496 3000

Aubrey Powell (Corporate Finance)

Rachel Hayes (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRDGGDRLDXBGCB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.